REGN5459
Regeneron
['regn5459', 'multiple myeloma']
regn5459 appears safe and can produce durable responses in patients with relapsed or refractory multiple myeloma, a phase 1/2 study presented at aacr 2023 suggests. #aacr23 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.